FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

G & W Laboratories Ciclopirox Olamine Cream Recall

Ciclopirox Olamine Cream USP, 0

G & W Laboratories, Inc. · South Plainfield, NJ

Risk level
Class III
Reported by FDA
Feb 14, 2018
Recall ID
D-0250-2018
Check your lot numberHow we source this data

Summary

G & W Laboratories recalled Ciclopirox Olamine Cream starting Jan 19, 2018. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0250-2018 on Feb 14, 2018. Reason: Discoloration: Product is supposed to be a white to off white homogenous cream and may have intermittent yellow discoloration. Status: Terminated.

Why it was recalled

Discoloration: Product is supposed to be a white to off white homogenous cream and may have intermittent yellow discoloration.

Product description

Ciclopirox Olamine Cream USP, 0.77%, packaged in a) 15 g tubes (NDC 0713-0638-15); b) 30 g tubes (NDC 0713-0638-31); and c) 90 g tubes (NDC 0713-0638-18), Rx Only, Manufactured by: G&W Laboratories, Inc., South Plainfield, NJ 07080.

Lot numbers, UPCs & expiration codes

Lot #: a) 1002896, Exp 09/18; 1005797, Exp 05/19; 1006100, Exp 07/19; b) 1002561, Exp 06/18; 1002897, Exp 09/18; 1005798, Exp 05/19; 1006101, Exp 07/19; c) 1002898, Exp 10/18; 1004283, Exp 12/18; 1005837, Exp 05/19; 1006321, 1006322, Exp 07/19

Where it was sold

Nationwide in the USA and Puerto Rico

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0250-2018
Classification
Class III
Status
Terminated
Recall initiated
Jan 19, 2018
FDA report date
Feb 14, 2018
Quantity
142,236 tubes
Recall type
Voluntary: Firm initiated
Recalling firm
G & W Laboratories, Inc.

Original FDA data

Every field from FDA enforcement report D-0250-2018, exactly as published.

Show all FDA fields
City
South Plainfield
State
NJ
Status
Terminated
Country
United States
Event ID
78974
Address
200 Helen St
Code information
Lot #: a) 1002896, Exp 09/18; 1005797, Exp 05/19; 1006100, Exp 07/19; b) 1002561, Exp 06/18; 1002897, Exp 09/18; 1005798, Exp 05/19; 1006101, Exp 07/19; c) 1002898, Exp 10/18; 1004283, Exp 12/18; 1005837, Exp 05/19; 1006321, 1006322, Exp 07/19
Postal code
07080-3800
Report date
Feb 14, 2018
Product type
Drugs
Recall number
D-0250-2018
Classification
Class III
Recalling firm
G & W Laboratories, Inc.
Product quantity
142,236 tubes
Termination date
Feb 3, 2020
Reason for recall
Discoloration: Product is supposed to be a white to off white homogenous cream and may have intermittent yellow discoloration.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Ciclopirox Olamine Cream USP, 0.77%, packaged in a) 15 g tubes (NDC 0713-0638-15); b) 30 g tubes (NDC 0713-0638-31); and c) 90 g tubes (NDC 0713-0638-18), Rx Only, Manufactured by: G&W Laboratories, Inc., South Plainfield, NJ 07080.
Distribution pattern
Nationwide in the USA and Puerto Rico
Recall initiation date
Jan 19, 2018
Initial firm notification
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Center classification date
Feb 2, 2018

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0250-2018, published Feb 14, 2018. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls